KORU Medical Systems, Inc. filed a Form 8-K on November 10, 2026, announcing its financial results for the third fiscal quarter ended September 30, 2026, and updating financial guidance for the fiscal year ended December 31, 2026.
Key Highlights
- Reporting period: Third fiscal quarter ended September 30, 2026, with a fiscal year-end of December 31, 2026.
- Guidance update: The company disclosed updated financial guidance for the fiscal year ended December 31, 2026, alongside the quarterly results.
- Conference call: A related conference call was scheduled for November 10, 2026 at 4:30 p.m. Eastern Time.
- Non-GAAP measures: The company referenced non-GAAP measures "adjusted EBITDA" and "adjusted diluted EPS" in both the press release and the conference call.
- Signed by: Adam Kalbermatten, Chief Executive Officer, on November 10, 2026.
KORU Medical Discloses Q3 2026 Financials and Updated Full-Year Guidance
KORU Medical Systems, Inc. (NASDAQ:KRMD) furnished a press release as Exhibit 99.1 to this Current Report, covering financial results for the quarter ended September 30, 2026, and an update to guidance for the full fiscal year ending December 31, 2026, according to the filing. The press release and accompanying conference call both reference non-GAAP financial measures, with a reconciliation of GAAP to non-GAAP results provided in Exhibit 99.1.
As described in the filing, the company defines "adjusted EBITDA" as earnings (net loss/income) before depreciation and amortization, interest (income) net, litigation expense, and stock-based compensation expense. The company states it uses this measure as "a supplemental internal measure for planning and forecasting overall expectations and for evaluating actual results against such expectations." Similarly, "adjusted diluted EPS" is defined as reported diluted earnings per share adjusted for depreciation and amortization, interest (income) net, litigation expense, and stock-based compensation expense.
The filing notes that "KORU Medical strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety" and cautions that its non-GAAP measures "may differ from similar measures used by other companies, even when similar terms are used to identify such measures." The information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, according to the filing.
What Was Disclosed
KORU Medical Systems filed an 8-K on November 10, 2026, furnishing a press release with Q3 2026 financial results and updated fiscal year 2026 guidance, along with definitions and cautions regarding non-GAAP measures used in its reporting.



Please wait processing your request...